GB0226149D0 - Inhibitors - Google Patents

Inhibitors

Info

Publication number
GB0226149D0
GB0226149D0 GB0226149A GB0226149A GB0226149D0 GB 0226149 D0 GB0226149 D0 GB 0226149D0 GB 0226149 A GB0226149 A GB 0226149A GB 0226149 A GB0226149 A GB 0226149A GB 0226149 D0 GB0226149 D0 GB 0226149D0
Authority
GB
United Kingdom
Prior art keywords
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0226149A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astex Technology Ltd
Original Assignee
Astex Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astex Technology Ltd filed Critical Astex Technology Ltd
Priority to GB0226149A priority Critical patent/GB0226149D0/en
Publication of GB0226149D0 publication Critical patent/GB0226149D0/en
Priority to US10/519,922 priority patent/US20060063782A1/en
Priority to AU2003246927A priority patent/AU2003246927A1/en
Priority to PCT/GB2003/002864 priority patent/WO2004004720A1/en
Priority to EP03762777A priority patent/EP1545523A1/en
Priority to JP2004518947A priority patent/JP2005538975A/en
Ceased legal-status Critical Current

Links

GB0226149A 2002-07-03 2002-11-08 Inhibitors Ceased GB0226149D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0226149A GB0226149D0 (en) 2002-11-08 2002-11-08 Inhibitors
US10/519,922 US20060063782A1 (en) 2002-07-03 2003-07-03 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
AU2003246927A AU2003246927A1 (en) 2002-07-03 2003-07-03 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
PCT/GB2003/002864 WO2004004720A1 (en) 2002-07-03 2003-07-03 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
EP03762777A EP1545523A1 (en) 2002-07-03 2003-07-03 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
JP2004518947A JP2005538975A (en) 2002-07-03 2003-07-03 3- (Hetero) arylmethoxypyridines and their analogs as p38 MAP kinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0226149A GB0226149D0 (en) 2002-11-08 2002-11-08 Inhibitors

Publications (1)

Publication Number Publication Date
GB0226149D0 true GB0226149D0 (en) 2002-12-18

Family

ID=9947501

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0226149A Ceased GB0226149D0 (en) 2002-07-03 2002-11-08 Inhibitors

Country Status (1)

Country Link
GB (1) GB0226149D0 (en)

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
PL373649A1 (en) Kinase inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
SI1569907T1 (en) Nicotinamide-based kinase inhibitors
AU2003300832A8 (en) Nf-kappab inhibitors
EP1499336A4 (en) Protease inhibitors
EP1558609A4 (en) Kinase inhibitors
EP1532133A4 (en) Nf-:b inhibitors
GB2412372B (en) Pyrazine-based tubulin inhibitors
AU2003230392A8 (en) Beta-secretase inhibitors
EP1570847A4 (en) Phosphodiesterase 10a inhibitors
EP1569907A4 (en) Nicotinamide-based kinase inhibitors
AU2003299901A8 (en) Thrombin inhibitors
AU2003269984A8 (en) Protease inhibitors
AU2003224941A8 (en) Nf-kappab inhibitors
AU2003263738A8 (en) Protease inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2003304496A8 (en) Protease inhibitors
AU2003233642A8 (en) Protease inhibitors
GB0207488D0 (en) Inhibitors
GB0206031D0 (en) Inhibitors
GB0207491D0 (en) Inhibitors
GB0224102D0 (en) Inhibitors
GB0208094D0 (en) Inhibitors
GB0217330D0 (en) Inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)